Mergers and Acquisition Investigations

Insight Select Income Fund (NYSE: INSI)

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Insight Select Income Fund (NYSE: INSI) to KKR Income Opportunities Fund (NYSE: KIO). Under the terms of the proposed transaction, shareholders of Insight will receive shares of KKR and may elect to receive up to 5% of the consideration in cash.  KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or fill out the form on this page.

Arcadium Lithium plc (NYSE: ALTM)

ARCADIUM LITHIUM INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcadium Lithium plc – ALTM

Barnes Group Inc. (NYSE: B)

BARNES GROUP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Barnes Group Inc. – B

Smartsheet Inc. (NYSE: SMAR)

SMARTSHEET INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Smartsheet Inc. – SMAR

Sterling Bank and Trust, F.S.B. (NasdaqCM: SBT)

STERLING BANCORP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sterling Bancorp, Inc. – SBT

Evans Bancorp, Inc. (NYSE: EVBN)

EVANS BANCORP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Evans Bancorp, Inc. – EVBN

Gatos Silver, Inc. (NYSE: GATO)

GATOS SILVER INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Gatos Silver, Inc. – GATO

The First of Long Island Corporation (NasdaqCM: FLIC)

FIRST OF LONG ISLAND INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of The First of Long Island Corporation – FLIC

Better Choice Company Inc. (NYSE: BTTR)

BETTER CHOICE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Better Choice Company Inc. – BTTR

ARC Document Solutions, Inc. (NYSE: ARC)

ARC DOCUMENT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ARC Document Solutions, Inc. – ARC

CrossFirst Bankshares, Inc. (NasdaqGS: CFB)

CROSSFIRST BANKSHARES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CrossFirst Bankshares, Inc. – CFB

Stronghold Digital Mining, Inc. (NasdaqGM: SDIG)

STRONGHOLD DIGITAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Stronghold Digital Mining, Inc. – SDIG

Arch Resources, Inc. (NYSE: ARCH)

ARCH RESOURCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arch Resources, Inc. – ARCH

Kellanova (NYSE: K)

KELLANOVA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kellanova – K

Revance Therapeutics, Inc. (NasdaqGM: RVNC)

REVANCE THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Revance Therapeutics, Inc. – RVNC